Canada Life’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-71,296
| Closed | -$282K | – | 2780 |
|
|
2019
Q4 | $282K | Buy |
+71,296
| New | +$335K | ﹤0.01% | 1844 |
|
|
2019
Q3 | – | Sell |
-75,187
| Closed | -$456K | – | 2673 |
|
|
2019
Q2 | $456K | Hold |
75,187
| – | – | ﹤0.01% | 1802 |
|
|
2019
Q1 | $437K | Buy |
75,187
+3,729
| +5% | +$38.5K | ﹤0.01% | 1675 |
|
|
2018
Q4 | $886K | Buy |
71,458
+5,702
| +9% | +$96.1K | ﹤0.01% | 1452 |
|
|
2018
Q3 | $1.28M | Buy |
65,756
+2,641
| +4% | +$56.2K | ﹤0.01% | 1418 |
|
|
2018
Q2 | $1.61M | Hold |
63,115
| – | – | ﹤0.01% | 1320 |
|
|
2018
Q1 | $1.27M | Sell |
63,115
-823
| -1% | -$19.2K | ﹤0.01% | 1406 |
|
|
2017
Q4 | $1.28M | Buy |
63,938
+889
| +1% | +$17.5K | ﹤0.01% | 1425 |
|
|
2017
Q3 | $1.29M | Buy |
63,049
+300
| +0.5% | +$5.07K | ﹤0.01% | 1423 |
|
|
2017
Q2 | $928K | Buy |
62,749
+2,740
| +5% | +$45.7K | ﹤0.01% | 1549 |
|
|
2017
Q1 | $956K | Buy |
60,009
+3,253
| +6% | +$46.9K | ﹤0.01% | 1525 |
|
|
2016
Q4 | $715K | Hold |
56,756
| – | – | ﹤0.01% | 1600 |
|
|
2016
Q3 | $1.59M | Buy |
56,756
+10,025
| +21% | +$336K | ﹤0.01% | 1196 |
|
|
2016
Q2 | $1.63M | Buy |
46,731
+43,331
| +1,274% | +$1.36M | ﹤0.01% | 1147 |
|
|
2016
Q1 | $93K | Hold |
3,400
| – | – | ﹤0.01% | 1845 |
|
|
2015
Q4 | $116K | Hold |
3,400
| – | – | ﹤0.01% | 1661 |
|
|
2015
Q3 | $98K | Hold |
3,400
| – | – | ﹤0.01% | 1723 |
|
|
2015
Q2 | $152K | Buy |
+3,400
| New | +$128K | ﹤0.01% | 1554 |
|
Other funds holding DPLO
Canada Life's DPLO Position: Q1 2020 in Review
Canada Life sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 71,296 shares — an estimated $282K sold.
Canada Life first reported a position in DPLO in Q2 2015 and held it in 18 quarters. The position peaked at $1.63M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Canada Life reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Canada Life sold 71,296 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $282K.
- Canada Life first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 18 quarters.
- Canada Life's DIPLOMAT PHARMACY, INC. position peaked at $1.63M in Q2 2016.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Canada Life's 13F filing for Q1 2020, filed 14 May 2020.